Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Rev1 Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 244
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 156
Rounds per year 12.84
Lead investments 31
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.35
Exits 18
Key employees 10
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Software
  • Health Care
  • Information Technology
  • Biotechnology
  • SaaS
Summary

Rev1 Ventures is the famous VC, which was founded in 2005. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Columbus.

Opposing the other organizations, this Rev1 Ventures works on 23 percentage points less the average amount of lead investments. When the investment is from Rev1 Ventures the average startup value is 5-10 millions dollars. The fund is generally included in 7-12 deals every year. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 1 - 5 millions dollars. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Rev1 Ventures, startups are often financed by NCT Ventures, Charter Life Sciences, 10Xelerator. The meaningful sponsors for the fund in investment in the same round are NCT Ventures, JumpStart Inc., Tamarind Hill. In the next rounds fund is usually obtained by JumpStart Inc., Tamarind Hill, PointGuard Ventures.

Besides them, we counted 10 critical employees of this fund in our database.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Information Technology, Enterprise Software. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Unific, Seen Digital Media, Inc., ClearSaleing

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Myoptechs

Manufacturing
Medical Device
$2M04 Sep 2024 Columbus, Ohio, United States

Power to Hydrogen

Clean Energy
CleanTech
Energy Storage
Oil and Gas
$18M19 Aug 2024 Columbus, Ohio, United States

Niobium Microsystems

$5M07 May 2024 Dayton, Ohio, United States

Trace 3D

$2M24 Apr 2024 -

CHAMPtitles

Blockchain
Information Services
Information Technology
$18M27 Mar 2024 Cleveland, Ohio, United States

Redi.Health

B2C
Health Care
$14M28 Feb 2024 Columbus, Ohio, United States

Basking Biosciences

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$55M30 Jan 2024 Durham, North Carolina, United States

Clarametyx Biosciences

Medical
Pharmaceutical
$33M05 Jan 2024 Columbus, Ohio, United States

Invirsa

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$7M14 Jun 2023 Columbus, Ohio, United States
News
Eikonoklastes Closes Series A Funding

– Eikonoklastes Therapeutics from Cincinnati, Ohio develops immunotherapies to treat a broad range of cancers beginning with Triple Negative Breast Cancer (TNBC), a lethal form of breast cancer that comprises 15% of all breast cancers.
– The company raised an undisclosed amount in Series A funding.
– The round was led by CincyTech with participation from New York-based Elk Capital Ventures, Jobs Ohio, Rev1, and other undisclosed investors.
– The new investment will be used to conduct Investigational New Drug (IND) enabling studies for Eikonoklastes Therapeutics’ L-ICON3 immune conjugate platform.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Rev1 Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 244
Average round size 2M
Rounds per year 12.84
Peak activity year 2017
Lead investments 31
Follow on index 0.35
Exits 18
Group Appearance index 0.46

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Myoptechs

Manufacturing
Medical Device
$2M04 Sep 2024 Columbus, Ohio, United States

Power to Hydrogen

Clean Energy
CleanTech
Energy Storage
Oil and Gas
$18M19 Aug 2024 Columbus, Ohio, United States

Niobium Microsystems

$5M07 May 2024 Dayton, Ohio, United States

Trace 3D

$2M24 Apr 2024 -

CHAMPtitles

Blockchain
Information Services
Information Technology
$18M27 Mar 2024 Cleveland, Ohio, United States

Redi.Health

B2C
Health Care
$14M28 Feb 2024 Columbus, Ohio, United States

Basking Biosciences

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$55M30 Jan 2024 Durham, North Carolina, United States

Clarametyx Biosciences

Medical
Pharmaceutical
$33M05 Jan 2024 Columbus, Ohio, United States

Invirsa

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$7M14 Jun 2023 Columbus, Ohio, United States
Crunchbase icon

Content report

The following text will be sent to our editors: